A Serine Protease from a Detergent-Soluble

Total Page:16

File Type:pdf, Size:1020Kb

A Serine Protease from a Detergent-Soluble A Serine Protease from a Detergent-soluble Extract of Leishmania (Leishmania) amazonensis Raquel Elisa da Silva Lopeza,* and Salvatore Giovanni De Simonea,b a Laborato´ rio de Bioquı´mica de Proteı´nas e Peptı´deos, Departamento de Bioquı´mica e Biologia Molecular, Instituto Oswaldo Cruz, FIOCRUZ, Av. Brasil 4365, 21045-900, Rio de Janeiro, RJ, Brasil. Fax: +55215903495. E-mail: [email protected] b Departamento de Biologia Celular e Molecular, Instituto de Biologia, Universidade Federal Fluminense, Nitero´ i, RJ, Brasil * Author for correspondence and reprint requests Z. Naturforsch. 59c, 590Ð598 (2004); January 22/March 18, 2004 Proteases mediate important crucial functions in parasitic diseases, and their characteriza- tion contributes to the understanding of host-parasite interaction. A serine protease was purified about 43-fold with a total recovery of 60% from a detergent-soluble extract of pro- mastigotes of Leishmania amazonensis. The purification procedures included aprotinin-agar- ose affinity chromatography and gel filtration high performance liquid chromatography. The molecular mass of active enzyme was 110 kDa by native gel filtration HPLC and by SDS- PAGE gelatin under non-reducing conditions. Under conditions of reduction using SDS- PAGE gelatin analyses the activity of enzyme was observed in two proteins of 60 and 45 kDa, suggesting that the enzyme may be considered as a dimer. The Leishmania protease was not glycosylated, and its isoelectric point (pI) was around 4.8. The maximal protease activity was α ρ at pH 7.0 and 28 ∞C, using -N- -tosyl-L-arginyl-methyl ester (l-TAME) as substrate. Assays of thermal stability indicated that this enzyme was totally denatured after pre-treatment at 42 ∞C for 12 min and preserved only 20% of its activity after pre-treatment at 37 ∞C for 24 h, in the absence of substrate. Hemoglobin, bovine serum albumin (BSA), ovalbumin and gela- tin were hydrolyzed by Leishmania protease. Inhibition studies indicated that the enzyme belonged to a serine protease class because of a significant impediment by serine protease inhibitors such as benzamidine, aprotinin, and antipain. The activity of the present serine protease is negatively modulated by calcium and zinc and positively modulated by manganese ions. This is the first study that reports the purification of a protease from a detergent-soluble extract of Leishmania species. Key words: Leishmania (Leishmania) amazonensis, Serine Protease, Characterization Introduction ics and subtropics, and the increment of Protozoan parasites of the genus Leishmania Leishmania transmission and dissemination has are associated with a broad spectrum of diseases been mainly attributed to blood transfusion and ranging from self-healing cutaneous lesions to le- human immunodeficiency virus (HIV) co-infec- thal visceral consequences (Alexander and Rus- tion (Desjeux, 1999). Leishmania are dimorphic sell, 1992). Leishmaniasis are endemic in the trop- obligate intracellular parasites: Flagellated pro- mastigotes replicate in the gut of the sandfly vec- tor, and their transmission to humans or other ver- α Abbreviations: ACN, acetonitrile; BAME, N- -benzoyl- tebrate hosts occurs when the vector feeds on L-arginyl-methyl ester; BHI, brain heart infusion; Bz, benzoyl; CHAPS, 3-[(3-cholamidopropyl) dimethylam- blood. These promastigotes are internalized by monio]-1-propanesulfonate; DTT, dithiothreitol; EDTA, mononuclear phagocytic system cells and undergo ethylenediaminetetraacetic acid; E-64, L-trans-epoxysuc- transformation into the nonmotile amastigote cinyleucylamido-(4-guanidino) butane; HPLC, high per- form that maintain the infection, leading to the formance liquid chromatography; PBS, phosphate buffer saline; pI, isoelectric point; PMSF, phenylmethylsulfonyl destruction of host tissues and invasion of new fluoride; ρ-NA, paranitroanilide; SBTI, soybean trypsin cells (Colmenares et al., 2001). Consequently the inhibitor; SDS-PAGE, polyacrylamide gel electrophore- expression of many molecules is responsible for α ρ sis containing sodium dodecyl sulfate; l-TAME, -N- - mechanisms triggered by parasites in order to tosyl-L-arginyl-methyl ester; TLCK, N-tosyl-lysine chlo- romethyl ketone; TFA, trifluoroacetic acid; TPCK, N- guarantee survival within the host. Among these tosyl-L-phenylalanine chloromethyl ketone. molecules proteases have received paramount at- 0939Ð5075/2004/0700Ð0590 $ 06.00 ” 2004 Verlag der Zeitschrift für Naturforschung, Tübingen · http://www.znaturforsch.com · D R. E. da Silva Lopez and S. Giovanni De Simone · A Serine Protease from Leishmania 591 tention due to their crucial roles in the parasite life has great activity against human connective tissue cycle and disease pathogenesis (Rosenthal, 1999; proteins, enabling parasite penetration of the host Sadij and McKerrow, 2002). They are involved in tissues (Ghendler et al., 1996). Furthermore, a chy- the host-parasite interaction, including digestion motrypsin-like protease of S. mansoni cercariae is of exogenous proteins for nutritive purposes (Ro- essential for host skin penetration and can be senthal, 1999), invasion of host cells and tissues found both in cercariae secretions and membranes (Roggwiller et al., 1996) and modification of host (Salter et al., 2000). Herein we describe the purifi- proteins (Caler et al., 1998) which are very impor- cation procedure used and give some characteris- tant for parasite survival. Leishmania proteases tics of serine protease from a detergent-soluble ex- have been studied for almost three decades, and tract of Leishmania amazonensis promastigotes, some functions have been proposed for these en- an enzyme which definitely differs from the other zymes (Coombs, 1982). The importance of Leish- known serine peptidases of this parasite (Ribeiro mania proteases has been confirmed by the find- de Andrade et al., 1998). ings that specific protease inhibitors killed Leishmania parasites and reduced the evolution of Materials and Methods leishmaniatic lesions (Sadij and McKerrow, 2002). Parasites Serine proteases (EC 3.4.21) are among the most extensively studied enzymes and participate Promastigote forms of L. amazonensis (IOC in numerous physiological phenomena such as 575; IFLA/BR/67/PH8) were maintained at 28 ∞C blood clotting and complement activation (Raw- in brain heart infusion (BHI) medium (Difco, ling and Barret, 1994). Serine proteases of patho- Detroit, USA) supplemented with 10% (v/v) genic parasites play crucial roles in host-parasite heat-inactivated fetal-calf serum. For large-scale interaction, and their characterization is crucial to cultivation (2 l), the cultures were maintained at elucidate their functions in parasite physiology room temperature (25 ∞C) in Roller bottles using and parasite-host interaction. The majority of par- a Cel-Gro Rotator (Lab-Line Model, Thomas Sci- asite serine proteases has been isolated from entific, New Jersey, USA). Cell growth was esti- water-soluble extracts and is involved in mecha- mated by counting the parasites in a Neubauer nisms of host invasion (Roggwiller et al., 1996; chamber. Caler et al., 1998). The most notorious protozoan serine proteases involved in host cell invasion are Purification of Leishmania serine protease associated with Plasmodium falciparum and Try- The parasites (4.8 ¥ 1010) were harvested by cen- panossoma cruzi. Malarial proteases digest cyto- trifugation (3,000 ¥ g for 15 min at 4 ∞C) at the log plasmatic membrane proteins of red blood cells phase (4th day of cultivation) and washed three (glycophorin and band 3 proteins) thereby afford- times in cold phosphate buffer saline (PBS) ing invasion and infection by the parasite, whereas (pH 7.2) by centrifugation (3,000 ¥ g for 15 min at specific proteases inhibitors prevent such (Rogg- 4 ∞C). Parasite lysates were prepared in PBS by willer et al., 1996). Mammalian cell invasion by T. seven cycles of freezing and thawing (Ð 80 ∞C/ cruzi is mediated by a serine oligopeptidase B 37 ∞C). Finally, the cell lysate was centrifuged which is responsible for the generation of a pep- (100,000 ¥ g for 60 min at 4 ∞C), the supernatant tide hormone-like factor that triggers Ca2+ signal- was discarded and the pellet was ressuspended ing, facilitating parasite infection (Caler et al., using 10 ml of extraction buffer containing 0.5% 1998). Deletion of the gene encoding oligopepti- CHAPS, 0.01 m Tris-HCl, pH 7.5, and centrifuged dase B results in a marked deficiency for host cell (100,000 ¥ g for 60 min at 4 ∞C). The clear super- invasion, as well as reducing the establishment of natant was dialyzed overnight at 4 ∞C against infections in mice (Caler et al., 1998). 0.01 m Tris-HCl, pH 7.5, containing 0.1% CHAPS. Proteases of membrane or membrane-associ- Insoluble material was removed by centrifugation ated proteases require detergents for their extrac- (100,000 ¥ g, 60 min) and the clear supernatant tion, isolation and purification, because of the low loaded on to an aprotinin-agarose affinity column solubility in aqueous systems. Schistosoma man- (2.5 ml gel) previously equilibrated with 0.01 m soni has a membrane-associated serine protease of Tris-HCl, pH 7.5, 0.1% CHAPS containing 5 mm 28 kDa. This enzyme is anchored to the tegu- CaCl2. After exhaustive washing (20 bed volumes) mental membrane of schistosomula by lipids and the active material was eluted with 0.01 m Tris- 592 R. E. da Silva Lopez and S. Giovanni De Simone · A Serine Protease from Leishmania HCl, pH 7.5, containing 1.5 m NaCl. Fractions of Determination of optimal pH, temperature and 1 ml were collected on ice, the absorption at heat stability 280 nm of effluents was monitored to detect the The assays for pH dependency were carried out protein peak and the enzymatic activity of the incubating the enzyme (2 µg) for 30 min at room fractions was assayed using α-N-ρ-tosyl- -arginyl- L temperature with 0.25 mml-TAME in solutions methyl ester (l-TAME) as substrate. The enzyme with different pH values. The buffers used were active fractions were pooled and concentrated in as follows: 100 mm sodium citrate (pH 5.0/6.0) and Microcon (Amicon) concentrators (3-kDa cut-off Tris-HCl (pH 7.0/9.0), all buffers containing 0.1% membrane) at 4 ∞C.
Recommended publications
  • The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome Is Evolutionarily Conserved
    bioRxiv preprint doi: https://doi.org/10.1101/2020.09.28.317750; this version posted September 29, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. The Global Architecture Shaping the Heterogeneity and Tissue-Dependency of the MHC Class I Immunopeptidome is Evolutionarily Conserved Authors Peter Kubiniok†1, Ana Marcu†2,3, Leon Bichmann†2,4, Leon Kuchenbecker4, Heiko Schuster1,5, David Hamelin1, Jérome Despault1, Kevin Kovalchik1, Laura Wessling1, Oliver Kohlbacher4,7,8,9,10 Stefan Stevanovic2,3,6, Hans-Georg Rammensee2,3,6, Marian C. Neidert11, Isabelle Sirois1, Etienne Caron1,12* Affiliations *Corresponding and Leading author: Etienne Caron ([email protected]) †Equal contribution to this work 1CHU Sainte-Justine Research Center, Montreal, QC H3T 1C5, Canada 2Department of Immunology, Interfaculty Institute for Cell Biology, University of Tübingen, Tübingen, Baden-Württemberg, 72076, Germany. 3Cluster of Excellence iFIT (EXC 2180) "Image-Guided and Functionally Instructed Tumor Therapies", University of Tübingen, Tübingen, Baden-Württemberg, 72076, Germany. 4Applied Bioinformatics, Dept. of Computer Science, University of Tübingen, Tübingen, Baden- Württemberg, 72074, Germany. 5Immatics Biotechnologies GmbH, Tübingen, 72076, Baden-Württemberg, Germany. 6DKFZ Partner Site Tübingen, German Cancer Consortium (DKTK), Tübingen, Baden- Württemberg, 72076, Germany. 7Institute for Bioinformatics and Medical Informatics,
    [Show full text]
  • (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002
    USOO6395889B1 (12) United States Patent (10) Patent No.: US 6,395,889 B1 Robison (45) Date of Patent: May 28, 2002 (54) NUCLEIC ACID MOLECULES ENCODING WO WO-98/56804 A1 * 12/1998 ........... CO7H/21/02 HUMAN PROTEASE HOMOLOGS WO WO-99/0785.0 A1 * 2/1999 ... C12N/15/12 WO WO-99/37660 A1 * 7/1999 ........... CO7H/21/04 (75) Inventor: fish E. Robison, Wilmington, MA OTHER PUBLICATIONS Vazquez, F., et al., 1999, “METH-1, a human ortholog of (73) Assignee: Millennium Pharmaceuticals, Inc., ADAMTS-1, and METH-2 are members of a new family of Cambridge, MA (US) proteins with angio-inhibitory activity', The Journal of c: - 0 Biological Chemistry, vol. 274, No. 33, pp. 23349–23357.* (*) Notice: Subject to any disclaimer, the term of this Descriptors of Protease Classes in Prosite and Pfam Data patent is extended or adjusted under 35 bases. U.S.C. 154(b) by 0 days. * cited by examiner (21) Appl. No.: 09/392, 184 Primary Examiner Ponnathapu Achutamurthy (22) Filed: Sep. 9, 1999 ASSistant Examiner William W. Moore (51) Int. Cl." C12N 15/57; C12N 15/12; (74) Attorney, Agent, or Firm-Alston & Bird LLP C12N 9/64; C12N 15/79 (57) ABSTRACT (52) U.S. Cl. .................... 536/23.2; 536/23.5; 435/69.1; 435/252.3; 435/320.1 The invention relates to polynucleotides encoding newly (58) Field of Search ............................... 536,232,235. identified protease homologs. The invention also relates to 435/6, 226, 69.1, 252.3 the proteases. The invention further relates to methods using s s s/ - - -us the protease polypeptides and polynucleotides as a target for (56) References Cited diagnosis and treatment in protease-mediated disorders.
    [Show full text]
  • Serine Proteases with Altered Sensitivity to Activity-Modulating
    (19) & (11) EP 2 045 321 A2 (12) EUROPEAN PATENT APPLICATION (43) Date of publication: (51) Int Cl.: 08.04.2009 Bulletin 2009/15 C12N 9/00 (2006.01) C12N 15/00 (2006.01) C12Q 1/37 (2006.01) (21) Application number: 09150549.5 (22) Date of filing: 26.05.2006 (84) Designated Contracting States: • Haupts, Ulrich AT BE BG CH CY CZ DE DK EE ES FI FR GB GR 51519 Odenthal (DE) HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI • Coco, Wayne SK TR 50737 Köln (DE) •Tebbe, Jan (30) Priority: 27.05.2005 EP 05104543 50733 Köln (DE) • Votsmeier, Christian (62) Document number(s) of the earlier application(s) in 50259 Pulheim (DE) accordance with Art. 76 EPC: • Scheidig, Andreas 06763303.2 / 1 883 696 50823 Köln (DE) (71) Applicant: Direvo Biotech AG (74) Representative: von Kreisler Selting Werner 50829 Köln (DE) Patentanwälte P.O. Box 10 22 41 (72) Inventors: 50462 Köln (DE) • Koltermann, André 82057 Icking (DE) Remarks: • Kettling, Ulrich This application was filed on 14-01-2009 as a 81477 München (DE) divisional application to the application mentioned under INID code 62. (54) Serine proteases with altered sensitivity to activity-modulating substances (57) The present invention provides variants of ser- screening of the library in the presence of one or several ine proteases of the S1 class with altered sensitivity to activity-modulating substances, selection of variants with one or more activity-modulating substances. A method altered sensitivity to one or several activity-modulating for the generation of such proteases is disclosed, com- substances and isolation of those polynucleotide se- prising the provision of a protease library encoding poly- quences that encode for the selected variants.
    [Show full text]
  • Supplemental Materials Supplemental Table 1
    Electronic Supplementary Material (ESI) for RSC Advances. This journal is © The Royal Society of Chemistry 2016 Supplemental Materials Supplemental Table 1. The differentially expressed proteins from rat pancreas identified by proteomics (SAP vs. SO) No. Protein name Gene name ratio P value 1 Metallothionein Mt1m 3.35 6.34E-07 2 Neutrophil antibiotic peptide NP-2 Defa 3.3 8.39E-07 3 Ilf2 protein Ilf2 3.18 1.75E-06 4 Numb isoform o/o rCG 3.12 2.73E-06 5 Lysozyme Lyz2 3.01 5.63E-06 6 Glucagon Gcg 2.89 1.17E-05 7 Serine protease HTRA1 Htra1 2.75 2.97E-05 8 Alpha 2 macroglobulin cardiac isoform (Fragment) 2.75 2.97E-05 9 Myosin IF (Predicted) Myo1f 2.65 5.53E-05 10 Neuroendocrine secretory protein 55 Gnas 2.61 7.60E-05 11 Matrix metallopeptidase 8 Mmp8 2.57 9.47E-05 12 Protein Tnks1bp1 Tnks1bp1 2.53 1.22E-04 13 Alpha-parvin Parva 2.47 1.78E-04 14 C4b-binding protein alpha chain C4bpa 2.42 2.53E-04 15 Protein KTI12 homolog Kti12 2.41 2.74E-04 16 Protein Rab11fip5 Rab11fip5 2.41 2.84E-04 17 Protein Mcpt1l3 Mcpt1l3 2.33 4.43E-04 18 Phospholipase B-like 1 Plbd1 2.33 4.76E-04 Aldehyde dehydrogenase (NAD), cytosolic 19 2.32 4.93E-04 (Fragments) 20 Protein Dpy19l2 Dpy19l2 2.3 5.68E-04 21 Regenerating islet-derived 3 alpha, isoform CRA_a Reg3a 2.27 6.74E-04 22 60S acidic ribosomal protein P1 Rplp1 2.26 7.22E-04 23 Serum albumin Alb 2.25 7.98E-04 24 Ribonuclease 4 Rnase4 2.24 8.25E-04 25 Cct-5 protein (Fragment) Cct5 2.24 8.52E-04 26 Protein S100-A9 S100a9 2.22 9.71E-04 27 Creatine kinase M-type Ckm 2.21 1.00E-03 28 Protein Larp4b Larp4b 2.18 1.25E-03
    [Show full text]
  • Leishmania (L.) Amazonensis Peptidase Activities Inside the Living Cells and in Their Lysates
    Molecular & Biochemical Parasitology 184 (2012) 82–89 Contents lists available at SciVerse ScienceDirect Molecular & Biochemical Parasitology Leishmania (L.) amazonensis peptidase activities inside the living cells and in their lysates a a b c a Elide E. Caroselli , Diego M. Assis , Clara L. Barbiéri , Wagner A.S. Júdice , Maria A. Juliano , d a,∗ Marcos L. Gazarini , Luiz Juliano a Department of Biophysics, Escola Paulista de Medicina, Universidade Federal de São Paulo, SP, Brazil b Department of Microbiology, Immunology and Parasitology, Escola Paulista de Medicina, Universidade Federal de São Paulo, SP, Brazil c Centro Interdisciplinar de Investigac¸ ão Bioquímica, Universidade de Mogi das Cruzes, Av. Dr. Cândido Xavier de Almeida Souza 200, 08780-911 Mogi das Cruzes, Brazil d Department of Biosciences, Universidade Federal de São Paulo, Santos, Brazil a r t i c l e i n f o a b s t r a c t Article history: In this study we investigated the peptidase activity in Leishmania (L.) amazonensis live amastigote by con- Received 24 November 2011 focal microscopy using peptidyl-MCA as substrates, the hydrolysis of which releases the MCA fluorophore Received in revised form 13 March 2012 inside the cells. Cell pre-treatment with peptidase inhibitors indicated the presence of cysteine and ser- Accepted 27 April 2012 ine peptidases. It was noteworthy that Leishmania amastigotes incorporate only substrates (Z-FR-MCA, Available online 6 May 2012 Z-RR-MCA) or inhibitors (E64, TLCK) containing positively charged groups. The peptidase activities in the supernatants of amastigotes and promastigotes lysates were also evaluated with the same peptidyl-MCA Keywords: substrates and inhibitors in the pH range 4.5–9.0.
    [Show full text]
  • Supplementary Table 9. Functional Annotation Clustering Results for the Union (GS3) of the Top Genes from the SNP-Level and Gene-Based Analyses (See ST4)
    Supplementary Table 9. Functional Annotation Clustering Results for the union (GS3) of the top genes from the SNP-level and Gene-based analyses (see ST4) Column Header Key Annotation Cluster Name of cluster, sorted by descending Enrichment score Enrichment Score EASE enrichment score for functional annotation cluster Category Pathway Database Term Pathway name/Identifier Count Number of genes in the submitted list in the specified term % Percentage of identified genes in the submitted list associated with the specified term PValue Significance level associated with the EASE enrichment score for the term Genes List of genes present in the term List Total Number of genes from the submitted list present in the category Pop Hits Number of genes involved in the specified term (category-specific) Pop Total Number of genes in the human genome background (category-specific) Fold Enrichment Ratio of the proportion of count to list total and population hits to population total Bonferroni Bonferroni adjustment of p-value Benjamini Benjamini adjustment of p-value FDR False Discovery Rate of p-value (percent form) Annotation Cluster 1 Enrichment Score: 3.8978262119731335 Category Term Count % PValue Genes List Total Pop Hits Pop Total Fold Enrichment Bonferroni Benjamini FDR GOTERM_CC_DIRECT GO:0005886~plasma membrane 383 24.33290978 5.74E-05 SLC9A9, XRCC5, HRAS, CHMP3, ATP1B2, EFNA1, OSMR, SLC9A3, EFNA3, UTRN, SYT6, ZNRF2, APP, AT1425 4121 18224 1.18857065 0.038655922 0.038655922 0.086284383 UP_KEYWORDS Membrane 626 39.77128335 1.53E-04 SLC9A9, HRAS,
    [Show full text]
  • The Microbiota-Produced N-Formyl Peptide Fmlf Promotes Obesity-Induced Glucose
    Page 1 of 230 Diabetes Title: The microbiota-produced N-formyl peptide fMLF promotes obesity-induced glucose intolerance Joshua Wollam1, Matthew Riopel1, Yong-Jiang Xu1,2, Andrew M. F. Johnson1, Jachelle M. Ofrecio1, Wei Ying1, Dalila El Ouarrat1, Luisa S. Chan3, Andrew W. Han3, Nadir A. Mahmood3, Caitlin N. Ryan3, Yun Sok Lee1, Jeramie D. Watrous1,2, Mahendra D. Chordia4, Dongfeng Pan4, Mohit Jain1,2, Jerrold M. Olefsky1 * Affiliations: 1 Division of Endocrinology & Metabolism, Department of Medicine, University of California, San Diego, La Jolla, California, USA. 2 Department of Pharmacology, University of California, San Diego, La Jolla, California, USA. 3 Second Genome, Inc., South San Francisco, California, USA. 4 Department of Radiology and Medical Imaging, University of Virginia, Charlottesville, VA, USA. * Correspondence to: 858-534-2230, [email protected] Word Count: 4749 Figures: 6 Supplemental Figures: 11 Supplemental Tables: 5 1 Diabetes Publish Ahead of Print, published online April 22, 2019 Diabetes Page 2 of 230 ABSTRACT The composition of the gastrointestinal (GI) microbiota and associated metabolites changes dramatically with diet and the development of obesity. Although many correlations have been described, specific mechanistic links between these changes and glucose homeostasis remain to be defined. Here we show that blood and intestinal levels of the microbiota-produced N-formyl peptide, formyl-methionyl-leucyl-phenylalanine (fMLF), are elevated in high fat diet (HFD)- induced obese mice. Genetic or pharmacological inhibition of the N-formyl peptide receptor Fpr1 leads to increased insulin levels and improved glucose tolerance, dependent upon glucagon- like peptide-1 (GLP-1). Obese Fpr1-knockout (Fpr1-KO) mice also display an altered microbiome, exemplifying the dynamic relationship between host metabolism and microbiota.
    [Show full text]
  • Studies of Structure and Function of Tripeptidyl-Peptidase II
    Till familj och vänner List of Papers This thesis is based on the following papers, which are referred to in the text by their Roman numerals. I. Eriksson, S.; Gutiérrez, O.A.; Bjerling, P.; Tomkinson, B. (2009) De- velopment, evaluation and application of tripeptidyl-peptidase II se- quence signatures. Archives of Biochemistry and Biophysics, 484(1):39-45 II. Lindås, A-C.; Eriksson, S.; Josza, E.; Tomkinson, B. (2008) Investiga- tion of a role for Glu-331 and Glu-305 in substrate binding of tripepti- dyl-peptidase II. Biochimica et Biophysica Acta, 1784(12):1899-1907 III. Eklund, S.; Lindås, A-C.; Hamnevik, E.; Widersten, M.; Tomkinson, B. Inter-species variation in the pH dependence of tripeptidyl- peptidase II. Manuscript IV. Eklund, S.; Kalbacher, H.; Tomkinson, B. Characterization of the endopeptidase activity of tripeptidyl-peptidase II. Manuscript Paper I and II were published under maiden name (Eriksson). Reprints were made with permission from the respective publishers. Contents Introduction ..................................................................................................... 9 Enzymes ..................................................................................................... 9 Enzymes and pH dependence .............................................................. 11 Peptidases ................................................................................................. 12 Serine peptidases ................................................................................. 14 Intracellular protein
    [Show full text]
  • Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases
    Handbook of Proteolytic Enzymes Second Edition Volume 1 Aspartic and Metallo Peptidases Alan J. Barrett Neil D. Rawlings J. Fred Woessner Editor biographies xxi Contributors xxiii Preface xxxi Introduction ' Abbreviations xxxvii ASPARTIC PEPTIDASES Introduction 1 Aspartic peptidases and their clans 3 2 Catalytic pathway of aspartic peptidases 12 Clan AA Family Al 3 Pepsin A 19 4 Pepsin B 28 5 Chymosin 29 6 Cathepsin E 33 7 Gastricsin 38 8 Cathepsin D 43 9 Napsin A 52 10 Renin 54 11 Mouse submandibular renin 62 12 Memapsin 1 64 13 Memapsin 2 66 14 Plasmepsins 70 15 Plasmepsin II 73 16 Tick heme-binding aspartic proteinase 76 17 Phytepsin 77 18 Nepenthesin 85 19 Saccharopepsin 87 20 Neurosporapepsin 90 21 Acrocylindropepsin 9 1 22 Aspergillopepsin I 92 23 Penicillopepsin 99 24 Endothiapepsin 104 25 Rhizopuspepsin 108 26 Mucorpepsin 11 1 27 Polyporopepsin 113 28 Candidapepsin 115 29 Candiparapsin 120 30 Canditropsin 123 31 Syncephapepsin 125 32 Barrierpepsin 126 33 Yapsin 1 128 34 Yapsin 2 132 35 Yapsin A 133 36 Pregnancy-associated glycoproteins 135 37 Pepsin F 137 38 Rhodotorulapepsin 139 39 Cladosporopepsin 140 40 Pycnoporopepsin 141 Family A2 and others 41 Human immunodeficiency virus 1 retropepsin 144 42 Human immunodeficiency virus 2 retropepsin 154 43 Simian immunodeficiency virus retropepsin 158 44 Equine infectious anemia virus retropepsin 160 45 Rous sarcoma virus retropepsin and avian myeloblastosis virus retropepsin 163 46 Human T-cell leukemia virus type I (HTLV-I) retropepsin 166 47 Bovine leukemia virus retropepsin 169 48
    [Show full text]
  • Table 4. V. Cholerae Flexgene ORF Collection
    Table 4. V. cholerae FLEXGene ORF collection Reference Clone protein PlasmID clone GenBank Locus tag Symbol accession identifier FLEX clone name accession Product name VC0001 NP_062585 VcCD00019918 FLH200476.01F DQ772770 hypothetical protein VC0002 mioC NP_062586 VcCD00019938 FLH200506.01F DQ772771 mioC protein VC0003 thdF NP_062587 VcCD00019958 FLH200531.01F DQ772772 thiophene and furan oxidation protein ThdF VC0004 yidC NP_062588 VcCD00019970 FLH200545.01F DQ772773 inner membrane protein, 60 kDa VC0005 NP_062589 VcCD00061243 FLH236482.01F DQ899316 conserved hypothetical protein VC0006 rnpA NP_062590 VcCD00025697 FLH214799.01F DQ772774 ribonuclease P protein component VC0007 rpmH NP_062591 VcCD00061229 FLH236450.01F DQ899317 ribosomal protein L34 VC0008 NP_062592 VcCD00019917 FLH200475.01F DQ772775 amino acid ABC transporter, ATP-binding protein VC0009 NP_062593 VcCD00019966 FLH200540.01F DQ772776 amino acid ABC transproter, permease protein VC0010 NP_062594 VcCD00019152 FLH199275.01F DQ772777 amino acid ABC transporter, periplasmic amino acid-binding portion VC0011 NP_062595 VcCD00019151 FLH199274.01F DQ772778 hypothetical protein VC0012 dnaA NP_062596 VcCD00017363 FLH174286.01F DQ772779 chromosomal DNA replication initiator DnaA VC0013 dnaN NP_062597 VcCD00017316 FLH174063.01F DQ772780 DNA polymerase III, beta chain VC0014 recF NP_062598 VcCD00019182 FLH199319.01F DQ772781 recF protein VC0015 gyrB NP_062599 VcCD00025458 FLH174642.01F DQ772782 DNA gyrase, subunit B VC0016 NP_229675 VcCD00019198 FLH199346.01F DQ772783 hypothetical protein
    [Show full text]
  • Generated by SRI International Pathway Tools Version 25.0, Authors M
    Emticicia oligotrophica DSM 17448 NC_018748 by Pallavi Subhraveti1, Peter Midford, Ingrid Keseler1, Anamika Kothari1, Ron Caspi1, Peter D Karp1 --- 1SRI International Legend: Protein gene Transcription Start Adjacent genes drawn in the same color are within the same operon. This diagram was automatically generated by SRI International Pathway Tools version 25.0, authors M. Krummenacker and P.D. Karp. RNA gene Terminator Uncolored genes are not yet assigned to an operon. Pseudo-genes are crossed out with a big, diagonal X.
    [Show full text]
  • Expression of Treponema Denticola Oligopeptidase B in Escherichia Coli
    CURRENT MICROBIOLOGY Vol. 48 (2004), pp. 379–382 DOI: 10.1007/s00284-003-4168-4 Current Microbiology An International Journal © Springer-Verlag New York LLC 2004 Expression of Treponema denticola Oligopeptidase B in Escherichia coli Si Young Lee,1,2 J. Christopher Fenno2 1Department of Oral Microbiology, College of Dentistry, Research Institute of Oral Science, Kangnung National University, Kangnung, 201- 702, Korea 2Department of Biologic and Materials Sciences, School of Dentistry, University of Michigan, Ann Arbor, MI 48109-1078, USA Received: 4 June 2003 / Accepted: 16 September 2003 Abstract. Treponema denticola is a small anaerobic spirochete often isolated from periodontal lesions and closely associated with periodontal diseases. This bacterium possesses a particular arginine peptidase activity (previously called “BANA-peptidase” or “trypsin-like enzyme”) that is common to the three cultivable bacterial species most highly associated with severe periodontal disease. We recently reported the identification of the opdB locus that encodes the BANA-peptidase activity of T. denticola through DNA sequencing and mutagenesis studies. In the present study, we report expression of T. denticola OpdB peptidase in Escherichia coli. The opdB PCR product was cloned into pET30b and then transformed into the E. coli BL21 (DE3)/pLysS expression strain. Assays of enzymatic activities in E. coli containing T. denticola opdB showed BANA-peptidase activity similar to that of T. denticola. Availability of this recombinant expression system producing active peptidase will facilitate character- ization of the potential role of this peptidase in periodontal disease etiology. A specific complex of three cultivable anaerobic organ- bacterium expresses several virulence behaviors, such as isms including Treponema denticola, Porphyromonas adherence, cytotoxicity, iron sequestration, and locomo- gingivalis, and Bacteroides forsythus is associated with tion, which are likely to contribute to the periodontal periodontal disease severity [11].
    [Show full text]